Malignant Appendix Neoplasm — Trials

Malignant Appendix Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

72 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 19
Ph III recruiting: 1
Growth YoY: —
Industry share: 7%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07060014	NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers	recruiting	Phase 1	22	The Methodist Hospital Research InstituteOTHER	1	Sep 25, 2026	clinicaltrials
NCT07658196	TLR9 Immunotherapy for Peritoneal Carcinomatosis(TIPC)	recruiting	Phase 1	24	Brown UniversityOTHER	1	Aug 27, 2026	clinicaltrials